Form 4 for EXEL EXELIXIS, INC.
Accepted 2024-08-09 00:00:00 ET · period of report 2024-08-07 · accession 0000939767-24-000126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-09 | 2024-08-07 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale+OE | $25.00 | -95.0K | 521.0K | -15% | -$2.38M |
| D | 2024-08-09 | 2024-08-07 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | M - OptEx | $24.41 | +95.0K | 616.0K | +18% | +$2.32M |
| D | 2024-08-09 | 2024-08-07 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | M - OptEx | $0.00 | -95.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-07 | S | D | 95,000 | $25.00 | 520,990 | D | — | — | (F1) Includes 288,932 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
| 2 | Common | Common Stock | 2024-08-07 | M | A | 95,000 | $24.41 | 615,990 | D | — | — | (F1) Includes 288,932 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
| 3 | Derivative | Option (right to buy) | 2024-08-07 | M | D | 95,000 | $0.00 | 0 | D | $24.41 · 2018-10-03 to 2024-10-02 | 95,000 Common Stock | (F4) The option, representing the right to purchase a total of 95,000 shares of Exelixis, Inc. common stock became fully exercisable on October 3, 2021. |